Renal Dialysis
78
3
4
51
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Research Maturity
51 completed trials (65% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.8%
3 terminated out of 78 trials
94.4%
+7.9% vs benchmark
15%
12 trials in Phase 3/4
18%
9 of 51 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 51 completed trials
Clinical Trials (78)
Effect of Intradialytic Exercise on Left Ventricular Diastolic Function in Hemodialysis Patients
A Communication Tool to Assist Older Adults Facing Dialysis Choices
Expanded Hemodialysis Versus High-Volume Online Hemodiafiltration for Uremic Toxin Removal
Improving Continuous Renal Replacement Therapy Outcomes in Neonates and Infants Through Interdisciplinary Collaboration
Insights Into the Continuous Renal Replacement Therapy to Critical Ill Patients
Machine Learning and Artificial Intelligence Algorithms to Optimize the Performance and Delivery of Acute Dialysis
Exercise Effect on Psychological Distress of Patients Undergoing Hemodialysis at Al-Suwaiq Dialysis Center
Stretching Exercises for Dialysis Patients to Reduce Muscle Cramps
Levocarnitine for Reducing ESA Requirements in Hemodialysis Patients With Renal Anemia
Prospective, Multicentre, Randomized, Controlled, Cross-over Study on the Safety and Performance of the Biologic Fusion Option of DialogiQ Compared to Haemodialysis Without Biologic Fusion in Hypotension Prone Patients on Maintenance Haemodialysis
Vitamin D Supplementation in Kidney Disease
Effect of Whole-body Vibration Training in Patients With Renal Dialysis
Evaluating the Safety and Effectiveness of the InnAVasc Graft for Dialysis Access in Patients With Kidney Failure
Educational Intervention and Adherence
Impact of Hospital Pharmacist Intervention on Medication Management in Dialysis Patients
The Effect of Active Exercise on Maintenance Haemodialysis Patients
Effects of L-carnitine Therapy on the Heart of Maintenance Hemodialysis Patients
Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004)
Toxicokinetics of Protein-bound Uremic Toxins in ESRD Patients
Health Related Quality of Life and Cognitive Function Among Norwegian Dialysis Patients